---  
layout: startup_page  
title: "Entos Pharmaceuticals"  
id: "entospharma.com"  
permalink: "/entospharmaceuticalsentospharma.com05222025/"  
website: "https://www.entospharma.com"  
funding_round: "Strategic Investment"  
funding_amount: "$1M"  
investors: "CureDuchenne Ventures"  
about: "Entos Pharmaceuticals is a biotech company developing genetic medicines using its non-viral, redosable Fusogenix PLV delivery platform. They are focused on creating muscle-targeting therapeutics, specifically to deliver full-length dystrophin for the treatment of Duchenne muscular dystrophy (DMD). Their Fusogenix PLV platform offers a safe and effective means of delivering nucleic acid therapies."  
markets: "Biotech, Gene Therapy, Healthcare"  
hq: "Edmonton, Alberta, Canada"  
founded_year: "2016"  
linkedin: "https://www.linkedin.com/company/entospharmaceuticals/"  
twitter: "https://twitter.com/entospharma"  
instagram: ""  
facebook: "https://www.facebook.com/entospharma"  
crunchbase: "https://www.crunchbase.com/organization/entos-pharmaceuticals"  
pitchbook: "https://pitchbook.com/profiles/company/166302-37"  

date_display: "22-May-2025"  
date: "2025-05-22"

# SEO Optimization  
meta_title: "Entos Pharmaceuticals - Strategic Investment Funding ($1M)"  
meta_description: "Entos Pharmaceuticals, Entos Pharmaceuticals is a biotech company developing genetic medicines using its non-viral, redosable Fusogenix PLV delivery platform. They are focus..."  
meta_keywords: "Entos Pharmaceuticals, Biotech, Gene Therapy, Healthcare, Strategic Investment funding"  
canonical_url: "https://startup.projectstartups.com/entospharmaceuticalsentospharma.com05222025/"  
---